An application made for this job — a tailored resume and cover letter that speak straight to the posting.
AstraZeneca Amsterdam is seeking a P2P Finance Specialist to support the Procure-to-Pay cycle for the Netherlands entity. You will collaborate with the Group Financial Reporting team and interact with scientists and business users across functions.
The role combines finance operations with process improvements in a dynamic biotech setting. Candidates should have a finance degree, SAP and Coupa proficiency, strong Excel skills, and fluent English.
Own the numbers. Support the people who make the science happen.
In this role you will join our Group Financial Reporting team, which provides controllership activities to legal entities across the Netherlands, Belgium and the United Kingdom. We're standardising how we support those entities — same processes, same reporting, done well — with collaboration and continuous improvement at the centre of it. The team is based in Poland; this role focuses on the Dutch entity and you will be based in Amsterdam. Acerta Pharma, part of the AstraZeneca Group, is planning to relocate its offices from Oss to Amsterdam in early 2027. Until the relocation, you will work from our current Oss office one day per week, with the remaining office-based days in Amsterdam. Once the relocation is complete, your office-based work will be fully based in Amsterdam. This is a hands‑on position with defined responsibility rather than a strategic or oversight role. It offers a structured environment, close collaboration with an established team, and a clear route to broader responsibility over time.
Business user support and finance and accounting responsibilities make up the core of the role, covering the entire Procure-to-Pay cycle.
As a P2P Finance Specialist, you can expect much in return for your dedication. In addition to a competitive salary, you will enjoy
At AstraZeneca Amsterdam, we bring together two research groups, in haemato-oncology and next-generation cell therapy research. Together, they form our OncologyR&D hub in the Netherlands, working closely with colleagues in the US, Canada,Spainand the UK, to develop innovative treatments for patients with cancer. Our haematology R&D group was born asAcertaPharma, one of the Netherlands’ greatest biotech success stories. Its small-molecule BTK inhibitor has been approved by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of Chronic LymphocyticLeukemia(CLL) and Mantle Cell Lymphoma (MCL). In Amsterdam approximately 100 colleagues continue the development of new therapies forhaematologicalmalignancies under the AstraZeneca brand name. AstraZeneca’s Cell Therapy R&D team focuses on developing next-generation T-cell receptor (TCR) therapies targeting neoantigens in solidtumors. With a team of around 75 scientists, we work on both fullyindividualizedand shared neo-antigen approaches, with the aim of improving outcomes for patients with cancer. Our oncology research and development hub is anchored by our newstate-of-the-artlaboratories inOneHelixand the adjacent Plus Ultra Amsterdam building, bothlocatedon the Amsterdam University Medical Centre ( Amsterdam UMC) campus. Our hub is firmly positioned at the heart of the Dutch research community network, creating new opportunities for our people, our science, and the patients we work to transform outcomes for.
If you have any questions about this vacancy, our Recruitment Team, Karin Raadschelders / Caroline van Oppen is happy to answer your questions.
Contact: info@werkenbijastrazeneca.nl or by phone on +31(0)85 - 047 0244.
We don’t work with a fixed closing date; the vacancy will close as soon once we’ve found the right candidates.
06-Oct-2026
21-Oct-2026
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.